Massimo Imazio is an expert in Cardiology at Ospedale Santa Maria della Misericordia di Udine (Italy). As of October 2026, ScienceLeadR ranks Massimo Imazio in the top 1% of experts worldwide for Pericardial Effusion, Postpericardiotomy Syndrome and Pericarditis. Massimo Imazio has authored 688 publications, the most recent in 2026, and is an investigator in 23 clinical trials, 10 of them ongoing. SLR score: 2,712 (community average: 125). How the SLR is computed.

LeadR Profile

2 712 ScienceLeadR Reputation 2712
Network Map

Cardiology

Subspecialties: Internal Medicine - Public Health - Medical Imaging

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1999 - 2026

Source: PubMed

University of Turin

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 688

Citations

Citations: 31 211 1st author: 165 Last author: 76 Unique author: 61


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Early Introduction and Prolonged Full-Dose Anakinra Reduce Recurrence Risk After Discontinuation in Recurrent Pericarditis: An International Multicenter Cohort.
PMID 42885757 — heart diseases, pharmaceutical preparations, duration of therapy, pericarditis, maintenance, therapeutics
J Am Heart Assoc20260
The 'ten commandments' for the 2025 European Society of Cardiology guidelines on myocarditis and pericarditis.
PMID 42867067 — pericarditis, cardiology, myocarditis
Eur Heart J Top journal20260
Left ventricular outflow tract obstruction and myocardial edema burden in Takotsubo syndrome: acute and long-term outcomes-insights from the EVOLUTION registry.
PMID 42722296 — registries, cardiology, edema, takotsubo cardiomyopathy
Int J Cardiol20261
Cardiac Sarcoidosis: A Practical Guide for Cardiologists.
PMID 42814173 — heart diseases, sarcoidosis, cicatrix, arrhythmias, cardiac, adrenal cortex hormones, diagnosis, cardiologists, therapeutics, immunosuppression therapy, steroids
Curr Cardiol Rep20260
From Hippocrates to Biologics, The Evolving History of Pericarditis: A Review.
PMID 42804572 — cardiovascular system, pericarditis, diagnosis, therapeutics, history, blood circulation
Circulation Top journal20260

Clinical Studies 23

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3

By phase:

Phase 3 11
N/A 7
Phase 4 3
Phase 2 2

By status:

Recruiting 8
Completed 7
Unknown 5
Not yet recruiting 2
Terminated 1

By type:

Interventional 18
Observational 5

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 4
multicentric5to9 5
multicentricup10 11

Main Topics

Cohort/Consortium Investigators 15

Ongoing Clinical Trials

10 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Study of Transition Regimens to KPL 387 Monotherapy in Participants with Well Controlled Recurrent Pericarditis
2025-523234-66-00 — safety, pericarditis, therapeutics
Phase 2Recruiting2026
A Phase III Study to Investigate the Risk of Incident Heart Failure and Cardiovascular Death with Baxdrostat in Combination with Dapagliflozin in Participants with Increased Risk of Developing Heart Failure
2024-514506-32-00 — heart failure, heart
Phase 3Not yet recruiting2025
Bisoprolol for pericarditis Phase III randomized controlled clinical trial in patients with acute or recurrent pericarditis
2025-523015-11-00 — pericarditis, bisoprolol
Phase 3Recruiting2026
European Unified Registries for Heart Care Evaluation and Randomised Trials Italy
NCT07283809 — registries, myocardial infarction, heart, data collection, acute coronary syndrome, cardiology, st elevation myocardial infarction, non-st elevated myocardial infarction
N/ARecruiting2024
Italian Anderson Fabry Disease Cardiovascular Registry
NCT06806813 — registries, cardiovascular diseases, fabry disease
N/ARecruiting2022

LeadR Networks

Main global connection map